eMedicine Specialties > Ophthalmology > Neurologic Disorders

Chronic Progressive External Ophthalmoplegia: Follow-up

Author: Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences
Contributor Information and Disclosures

Updated: Dec 5, 2008

Follow-up

Further Outpatient Care

  • It is imperative that patients with chronic progressive external ophthalmoplegia (CPEO) receive regularly scheduled follow-up care in all areas, especially with cardiology, as primary cardiac dysfunction can occur at any time. This dysfunction often can be managed with an artificial pacemaker.

Complications

  • Cardiac problems
  • Esophageal dysfunction

Prognosis

  • The prognosis is guarded with a generally progressive disorder.

Patient Education

  • The following support group is available to patients: United Mitochondrial Disease Foundation, PO Box 1151, Monroeville, PA, 15146-1151.

Miscellaneous

Medicolegal Pitfalls

  • CPEO is a complex disorder but should be diagnosed as early as possible.

Special Concerns

  • A case documenting 2 pregnancies in a woman with CPEO discusses complications during these pregnancies of preterm labor and hypertension, but it cannot statistically relate these complications directly to CPEO.
 
Acknowledgments

The authors and editors of eMedicine gratefully acknowledge the contributions of previous author, Tracey A Schmucker, MD, to the development and writing of this article.



More on Chronic Progressive External Ophthalmoplegia

Overview: Chronic Progressive External Ophthalmoplegia
Differential Diagnoses & Workup: Chronic Progressive External Ophthalmoplegia
Treatment & Medication: Chronic Progressive External Ophthalmoplegia
Follow-up: Chronic Progressive External Ophthalmoplegia
Multimedia: Chronic Progressive External Ophthalmoplegia
References
[ CLOSE WINDOW ]

References

  1. Ahn J, Kim NJ, Choung HK, et al. Frontalis sling operation using silicone rod for the correction of ptosis in chronic progressive external ophthalmoplegia. Br J Ophthalmol. Sept 11,2008.

  2. Bresolin N, Bet L, Binda A, et al. Clinical and biochemical correlations in mitochondrial myopathies treated with coenzyme Q10. Neurology. Jun 1988;38(6):892-9. [Medline].

  3. Carlow TJ, Depper MH, Orrison WW Jr. MR of extraocular muscles in chronic progressive external ophthalmoplegia. AJNR Am J Neuroradiol. Jan 1998;19(1):95-9. [Medline].

  4. Cohen JM, Waiss B. Combination ptosis crutch and moisture chamber for management of progressive external ophthalmoplegia. J Am Optom Assoc. Oct 1997;68(10):663-7. [Medline].

  5. De Coo IF, Gussinklo T, Arts PJ, et al. A PCR test for progressive external ophthalmoplegia and Kearns-Sayre syndrome on DNA from blood samples. J Neurol Sci. Jul 1997;149(1):37-40. [Medline].

  6. Ewart RM, Burrows RF. Pregnancy in chronic progressive external ophthalmoplegia: a case report. Am J Perinatol. May 1997;14(5):293-5. [Medline].

  7. Fraunfelder FT, Roy FH, Randall J. Chronic progressive external ophthalmoplegia. In: Current Ocular Therapy. 5th ed. 2000:208-210.

  8. Kiyomoto BH, Tengan CH, Moraes CT, et al. Mitochondrial DNA defects in Brazilian patients with chronic progressive external ophthalmoplegia. J Neurol Sci. Nov 25 1997;152(2):160-5. [Medline].

  9. Kosmorsky G, Johns DR. Neuro-ophthalmologic manifestations of mitochondrial DNA disorders: chronic progressive external ophthalmoplegia, Kearns-Sayre syndrome, and Leber's hereditary optic neuropathy. Neurol Clin. Feb 1991;9(1):147-61. [Medline].

  10. Ogasahara S, Nishikawa Y, Yorifuji S, et al. Treatment of Kearns-Sayre syndrome with coenzyme Q10. Neurology. Jan 1986;36(1):45-53. [Medline].

  11. Peterson PL. The treatment of mitochondrial myopathies and encephalomyopathies. Biochim Biophys Acta. May 24 1995;1271(1):275-80. [Medline].

  12. Phillips CI, Gosden CM. Leber's hereditary optic neuropathy and Kearns-Sayre syndrome: mitochondrial DNA mutations. Surv Ophthalmol. May-Jun 1991;35(6):463-72. [Medline].

  13. Soejima K, Sakurai H, Nozaki M, et al. Surgical treatment of blepharoptosis caused by chronic progressive external ophthalmoplegia. Ann Plast Surg. Apr 2006;56(4):439-42. [Medline].

  14. Wallace DK, Sprunger DT, Helveston EM, et al. Surgical management of strabismus associated with chronic progressive external ophthalmoplegia. Ophthalmology. Apr 1997;104(4):695-700. [Medline].

[ CLOSE WINDOW ]

Further Reading

[ CLOSE WINDOW ]

Keywords

chronic progressive external ophthalmoplegia, CPEO, abiotrophic ophthalmoplegia, CPEO with ragged red fibers, oculocraniosomatic neuromuscular disease, ocular myopathy, Olson disease, Kearns-Sayre-Daroff syndrome, Kearns-Sayre syndrome, progressive external ophthalmoplegia plus, extraocular muscle paralysis

[ CLOSE WINDOW ]

Contributor Information and Disclosures

Author

Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences
Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology
Disclosure: Nothing to disclose.

Medical Editor

Edsel Ing, MD, FRCSC, Assistant Professor, Department of Ophthalmology & Vision Sciences, University of Toronto: Consulting Staff, Toronto East General Hospital
Edsel Ing, MD, FRCSC is a member of the following medical societies: American Academy of Ophthalmology, American College of Physician Executives, American Society of Contemporary Ophthalmology, Canadian Ophthalmological Society, Contact Lens Association of Ophthalmologists, North American Neuro-Ophthalmology Society, and Royal College of Physicians and Surgeons of Canada
Disclosure: Nothing to disclose.

Pharmacy Editor

Simon K Law, MD, PharmD, Assistant Professor of Ophthalmology, Jules Stein Eye Institute; Chief of Section of Ophthalmology Surgical Services, Department of Veterans Affairs Healthcare Center, West Los Angeles
Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, and Association for Research in Vision and Ophthalmology
Disclosure: Nothing to disclose.

Managing Editor

Brian R Younge, MD, Professor of Ophthalmology, Mayo Clinic School of Medicine
Brian R Younge, MD is a member of the following medical societies: American Medical Association, American Ophthalmological Society, and North American Neuro-Ophthalmology Society
Disclosure: Nothing to disclose.

CME Editor

Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri
Disclosure: Nothing to disclose.

Chief Editor

James P Gills, MD, Founder, St Luke's Cataract and Laser Institute; Professor, Department of Ophthalmology, University of South Florida College of Medicine
James P Gills, MD is a member of the following medical societies: American Academy of Ophthalmology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.